MedPath

Changes of Optical Quality During the Peak of the Covid-19 Pandemic

Completed
Conditions
SARS-CoV-2
Corneal Wavefront Aberration
Registration Number
NCT05882383
Lead Sponsor
Tianjin Eye Hospital
Brief Summary

To explore whether cornea structure, and optical quality are affected by the covid-19 infection.

Detailed Description

Participants with healthy corneas admitted to Tianjin Eye Hospital from November 25 to January 20, 2022 were followed up . At the end of the follow-up, the investigators recorded in detail whether the patients had undergone real-time reverse transcriptase polymerase chain reaction (covid-19 RT-PCR tests) testing, testing time and results. The presence of PCR-positive during follow-up is considered to be covid-19 infection; PCR-Negative and no symptoms of infection during the follow-up period are considered not infected; participants with symptoms but no PCR test were excluded from the study.Participants were divided into three groups according to the RT-PCR results and the presence or absence of symptoms of infection during follow-up. pentacam (Pentacam HR, Oculus, Wetzlar, Germany) was performed during follow-up and the results were recorded,and the data was statistically managed and compared.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria

Not provided

Exclusion Criteria
  1. corneal disease;
  2. ocular trauma;
  3. Pregnant and lactating women;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The value of cornea thickness1 months

The value of cornea thickness from pentacam during follow-up were compared, includig the thinnest point, apex of the cornea.

The value of cornea backscatter1 months

The value of cornea backscatter from pentacam during follow-up were compared, including anterior layer,central layer and posterior

The value of cornea aberration1 months

The value of aberration data from pentacam during follow-up were compared, including coma, spherical aberration, defocus, and astigmatism

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tianjin Eye Hospital

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath